Artículo
Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-B-Lactamase- Producing Escherichia coli
Autor/es | Retamar Gentil, Pilar
![]() ![]() ![]() ![]() ![]() ![]() López Cerero, Lorena ![]() ![]() ![]() ![]() ![]() ![]() ![]() Muniain Ezcurra, Miguel Angel Pascual Hernández, Álvaro ![]() ![]() ![]() ![]() ![]() ![]() ![]() Rodríguez-Baño, Jesús ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Departamento | Universidad de Sevilla. Departamento de Medicina Universidad de Sevilla. Departamento de Microbiología |
Fecha de publicación | 2013-07 |
Fecha de depósito | 2016-03-29 |
Publicado en |
|
Resumen | We investigated the impact of the piperacillin-tazobactam MIC in the outcome of 39 bloodstream infections due to extended-
spectrum-B-lactamase-producing Escherichia coli. All 11 patients with urinary tract infections ... We investigated the impact of the piperacillin-tazobactam MIC in the outcome of 39 bloodstream infections due to extended- spectrum-B-lactamase-producing Escherichia coli. All 11 patients with urinary tract infections survived, irrespective of the MIC. For other sources, 30-day mortality was lower for isolates with a MIC of <2 mg/liter than for isolates with a higher MIC (0% ver- sus 41.1%; P = 0.02) |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
20530603.pdf | 321.3Kb | ![]() | Ver/ | |